Document is current
Any future updates will be listed below
-
Authors
Jin, Yue
Yang, Fei
Rank, Christopher M.
Letovsky, Stanley
Ramge, Peter
Jochum, Simon
-
Funding
Funding for this research was provided by:
Roche Diagnostics International Ltd
- License Information
-
More Information
Article History
Received: 18 October 2024
Accepted: 25 November 2024
First Online: 26 December 2024
Declarations
:
: Dr Yue Jin is an employee of Roche Molecular Systems Inc. and a Roche stockholder; Dr Fei Yang is currently an employee of Phillip Morris International but was an employee of Roche Information Solutions Ltd at the time the study was conducted. Phillip Morris International has not been involved in the study or publication; Dr Christopher M. Rank is an employee of Roche Diagnostics GmbH and holds stocks/shares in F. Hofmann-La Roche Ltd; Dr Stanley Letovsky is a Labcorp employee and participates in employee stock plans; Dr Peter Ramge is an employee of Roche Diagnostics International Ltd. and a Roche stockholder; Dr Simon Jochum is an employee of Roche Diagnostics GmbH. The Elecsys Anti-SARS-CoV-2 S assay is approved under an Emergency Use Authorization in the US. ELECSYS is a trademark of Roche. All other product names and trademarks are the property of their respective owners.
: As a non-interventional study based on secondary data use, this study did not require informed consent or institutional/ethical review board approval.
